NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Jessica Ruth Bauman,Ankit Bharat,Debora S. Bruno,Joe Y. Chang,Lucian R. Chirieac,Thomas A. DAmico,Thomas J. Dilling,Jonathan E. Dowell,Scott N. Gettinger,Matthew A. Gubens,Aparna Hegde,Mark Hennon,Rudy P. Lackner,Michael Lanuti,Ticiana A. Leal,Jules Lin,Billy W. Loo,Christine M. Lovly,Renato Martins,Erminia Massarelli,Daniel Morgensztern,Thomas Ng,Gregory A. Otterson,Sandip Pravin Patel,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,Aditi P. Singh,James Stevenson,Alda L. Tam,Jane Yanagawa,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

2021

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Keywords:

Clinical Practice
Biomarker (medicine)
Oncology
Lung cancer
MEDLINE
Medicine
non small cell
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations